Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

Clinical trial NCT04032392 · UNKNOWN

Trial details

NCT number: NCT04032392
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-07-23
Primary completion: 2021-07-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.